Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 37.87

+33.8%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: kenhott	12/1/2005 11:41:44 AM
	Read Replies (2) of 566

Just looking around after the news this morning. Someone in the know should speak up since I don't. The obvious question is what happened. But the market is not wrong here to hit the stock hard since the comparator worked but the drug did not. That tells me that RIGL didn't just have a bad luck bum trial. For me, that calls into question the target syk. Which links to the PFE deal in asthma and the RA drug, all targeting syk. HepC is back to the drawing board for another turn around. R763 targets aurora which is a balance act since R763 will knock off fast growing normal cells in the body if it works. Can aurora be tuned just right? Of course MRK and Serono are betting that it is possible. Maybe the conference call will help to fill in some more info.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next